This website is intended for healthcare professionals only

Trending Topic

2 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Jérôme Avouac

Dear readers, It is a great pleasure to take on the role of Editor-in-Chief of touchREVIEWS in RMD, and I am grateful for the opportunity to introduce myself and to share my vision for the journal. I am a Professor of Rheumatology at UniversitĂ© Paris CitĂ© and a consultant rheumatologist at HĂ´pital Cochin (AP-HP) in […]

Speciality Filter
Or View our Specialities Page

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
Who's on your bench
touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

Your clinical career is shaped not only by what you know, but by who helps you navigate what comes next. Join us for the final episode in our mini-series exploring non-clinical skills that can help you thrive in your clinical career. Today we explore how to develop the right team around you to support your work, and what building that bench can mean for your career, and the life you build alongside it.

building media relationships
touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

We often focus on clinical excellence, but spend less time developing broader skills that could help us better lead with purpose and build more fulfilling, impactful careers. In this episode, part of a mini-series in partnership with LEADderm, Dr Jennifer Soung and Denise Mann explore how clinicians can engage with the media to educate, empower and extend their impact beyond the clinic.

Mark CompleteCompleted
BookmarkBookmarked
Jérôme Avouac

Dear readers, It is a great pleasure to take on the role of Editor-in-Chief of touchREVIEWS in RMD, and I am grateful for the opportunity to introduce myself and to share my vision for the journal. I am a Professor ...

Mark CompleteCompleted
BookmarkBookmarked

The landscape of rheumatic and musculoskeletal disease research continues to evolve at pace, driven by scientific innovation, interdisciplinary collaboration and an increasing appreciation of the heterogeneity and complexity of the conditions we treat. As we welcome readers to touchREVIEWS in ...

8 mins
Sponsored Content

Long-term dual IL-17A/F inhibition in PsA and axSpA.

Sponsored Content
touchFEATURE
For HCPs in: Denmark, Finland, France, Germany, Iceland, Ireland, Italy, Norway, Spain, Sweden and UK

Explore practical approaches to recognising and managing hereditary angioedema (HAE) to optimise treatment outcomes and improve quality of life for patients living with the disease.

Want to be featured in touchReviews in RMD?

Share your knowledge, influence clinical practices and enhance patient care in Immunology today!

  • Peer-reviewed, free-to-access
  • Accepting reviews, research and editorials
  • No article processing fees
  • Digital features and plain language summaries
  • Multichannel content distribution for maximum visibility
  • Submit an Article

Simple diagram of human lungs with anatomical details
Mark CompleteCompleted
BookmarkBookmarked

Interstitial lung disease (ILD) is recognized as one of the most frequent and potentially life-threatening pulmonary complications of systemic autoimmune rheumatic diseases (SARDs), a group of rare chronic inflammatory conditions characterized by autoimmune system dysregulation and chronic systemic inflammation. ILDs ...

Abstract digital representation of lungs in flames, symbolizing respiratory health and medical technology.
Mark CompleteCompleted
BookmarkBookmarked

The importance of multi-disciplinary clinics for the assessment of patients with interstitial lung disease (ILD) is well established, and these are usually led by chest physicians.1 The role of rheumatologists in such a setting has evolved more recently.2 The main ...

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

Whether you’re working in an agency, in a clinical role, or in academia, many healthcare professionals wonder what lies behind the doors of the pharmaceutical industry. In this episode, Gina is joined by Sian Kneller, Director of Global Content Design at GSK and Founder of The Agency Advantage, to unpack exactly what it takes to make the leap. With over 20 years’ experience, from medical writer to leading global medical affairs strategy, Sian now helps others make a successful move into pharma. In this episode she shares what the transition really looks like, which transferable skills matter most, and how you can stand out in a competitive field.

Translucent human skeleton wearing virtual reality headset on dark blue background
Mark CompleteCompleted
BookmarkBookmarked
Jordan Tsigarides, Benjamin Kannuralil Sabu, Mohammad Al-Amri

Virtual reality (VR) is an emergent technology with the potential for genuine impact as a novel, immersive digital therapeutic in healthcare. Within rheumatological conditions, pervasive symptoms including chronic pain and kinesiophobia (fear of movement) are difficult to manage using conventional ...

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

S3E3_Could senolytics change the treatment landscape of age-related diseases? In this episode, Nicky speaks with Prof. Georgina Ellison-Hughes from King’s College London about the groundbreaking field of senolytics and their potential to advance the treatment of age-related ...

Downloaded Save to Library Preview Crop Find Similar File #: 1193650659 Close-up of child experiencing knee pain, gently touching the affected area, with red highlight indicating inflammation
Mark CompleteCompleted
BookmarkBookmarked

Why do we need to identify arthritis? In children, joint pain occurs frequently; it is usually associated with activities or accidental falls and is generally short-lived. A small proportion of children have more persistent joint pain, and in this group, ...

syndemic
touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

In this episode we explore the concept of syndemics, how biology, society and the environment interact to shape health outcomes. We are joined by Dr Elena Nikiphorou (King’s College London), who is pioneering the use of syndemic thinking in inflammatory arthritis, and Dr Lisa Hamzah (St George’s Hospital, London), whose experience in HIV research offers unique insight into how this approach can transform care. Together we discuss how applying this framework, first developed in HIV research, could improve care for people with rheumatic and musculoskeletal diseases (RMDs) and help advance global health equity.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

In this episode of Visionary Voices, we welcome Associate Professor Grace Vincent from CQUniversity’s Appleton Institute. A leading expert on sleep and shift work, Grace explores how disrupted sleep affects physician health in both the short and long term, as well as its impact on safety and performance. We also discuss what this means for patient outcomes and share practical strategies to manage sleep loss.

Mark CompleteCompleted
BookmarkBookmarked

This narrative article aims to inspire confidence and courage to initiate the incremental process of developing myositis or other RD clinics.

childhood food allergies
touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

In this episode, we speak with leading paediatric allergist Prof. Helen Brough to explore the key factors behind why some children develop allergies to foods such as peanuts, and what we can do to help prevent them. We also examine the latest developments in managing food allergies and the innovations on the horizon that could transform how we treat them.

Physician burnout
touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.

38 mins
Sponsored Content

Join leading experts in EoE as they explore evolving guidelines, the role of type 2 inflammation, and the importance of long-term monitoring.

3 mins
Sponsored Content
touchFEATURE
For HCPs in: France, Germany, Italy, Spain, the UK, the Nordic countries (Denmark, Finland, Iceland, Norway and Sweden) and Austria only

Watch consultant immunologists Dr Dalm and Dr Chandra outline what APDS is, the common features of this disease and option for diagnosis, treatment and management.

Load More...
Advertisement
  • Introducing the touchIMMUNOLOGY Future Leaders 2025

    This year, we are celebrating our inaugural touchIMMUNOLOGY Future Leaders to recognize the outstanding talent that has entered our field in recent years. These individuals are set to innovate and transform the field in the years to come.

    Representing a diverse range of expertise from across the globe, these highly accomplished clinicians are among the brightest minds shaping the future of immunology. We had the pleasure of learning about their unique career journeys, motivations and the inspirations that have guided their paths. They also shared their perspectives on the most exciting developments in immunology today, along with their hopes for the future of the field.

    Advancing Osteoarthritis Research Through Immunology and Clinical Insight: An Interview with Dr Tom Appleton

    Tom Appleton

    St. Joseph’s Health Care London & Western University’s Schulich School of Medicine & Dentistry, London, ON, Canada

    Dr Tom Appleton is a future leader in the field of rheumatology, known for his dual expertise as a clinician and scientist. Based at St. Joseph’s Health Care London and Western University’s Schulich School of Medicine & Dentistry, his research focuses on the inflammatory mechanisms underlying osteoarthritis (OA), particularly the role of synovial macrophages.

    Canada

    “My advice to aspiring clinician-scientists is to embrace this dual role, maintaining clear boundaries and leveraging the strengths each domain brings to the other.”

    Bridging Bench and Bedside: Future Leader, Dr Sonali Bracken on Autoimmunity, B Cell Research, and the Future of Rheumatology

    Sonali Bracken

    Duke University, Durham, NC, USA

    Dr Sonali Bracken is a physician-scientist specializing in rheumatology and immunology at Duke University. Dr Bracken is currently a fourth-year research fellow in the Division of Rheumatology and Immunology at Duke University Medical Center, where she focuses on understanding how B cells contribute to autoimmune diseases. In recognition of her outstanding contributions to rheumatology, Dr Bracken received the 2024 Distinguished Fellow Award from the American College of Rheumatology.

    USA

    “It truly takes a village to raise a physician-scientist, and I am very grateful for all the individuals who have helped me along my career path.”

    Transforming IBD Care with Precision Medicine: An Exclusive Interview with Future Leader Dr Bram Verstockt

    Bram Verstockt

    University Hospitals Leuven & KU Leuven, Leuven, Belgium

    Dr Bram Verstockt, MD, PhD, is a leading clinician-scientist at University Hospitals Leuven and KU Leuven, whose work is rapidly shaping the future of inflammatory bowel disease (IBD) care. Dr Verstockt’s research interests span noninvasive monitoring with intestinal ultrasound, fatigue, IBD disease heterogeneity, intestinal organoids and precision medicine in IBD.

    Belgium

    “Precision medicine is a hope we all have, but I think what we all still struggle with is the translation from the wet lab to the clinic.”

    Advancing Rheumatology Through Innovation, Education and Patient-Centred Care: An Interview with Future Leader Dr Sham Santhanam

    Santhanam Sham

    Kauvery Hospitals, Chennai, India

    Dr Sham is a Senior Consultant Rheumatologist at Kauvery Hospitals, Chennai, India. In 2009, he earned his MD in general medicine from Kasturba Medical College and went on to specialise in rheumatology at Madras Medical College, Chennai. Dr Sham has extensive experience in treating a wide range of rheumatic diseases, with his current research focusing on systemic lupus erythematosus (SLE), vasculitis and interstitial lung disease (ILD).

    India

    “My long-term ambition is to make the management of AIRDs more patient-centric. I would like to empower patients by making them more aware of the disease, the management and expected outcomes.”

    Advancing Vasculitis Care and Medical Education: An Interview with Future Leader, Dr Brian Jaros

    Brian Jaros

    Northwestern University, Evanston, IL, USA

    Dr Brian Jaros is an Assistant Professor of Medicine in the Division of Rheumatology at Northwestern University, where he also serves as Associate Program Director of the Rheumatology Fellowship and Associate Director of the Vasculitis Center. His clinical and academic interests focus on vasculitis and medical education.

    “With an enormous work-force shortage looming in rheumatology, a focus on mentorship and training is more important than ever.”

    Introducing the touchIMMUNOLOGY Future Leaders 2025

    Editorial Board

    Introducing the Editorial Board of touchREVIEWS in Immunology, who support our mission to advance medical knowledge and practice by ensuring the integrity, relevance, and impact of the content we publish. Together, we strive to foster a vibrant academic community and contribute to the continuous improvement of healthcare worldwide.

    View All Members

    Peter Taylor

    University of Oxford, Oxford, UK

    Rheumatoid Arthritis

    Close Popup

    Peter Taylor

    Honorary Board Member

    Head of Clinical Sciences, Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK

    University of Oxford, Oxford, UK

    Biography

    Peter C Taylor holds the Norman Collison chair of musculoskeletal sciences at the University of Oxford and is a Fellow of St. Peter’s College. He is Head of Clinical Sciences at the Botnar Research Centre within the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences. He studied pre-clinical medical sciences at Gonville and Caius College at the University of Cambridge and his first degree was in Physiology. He subsequently studied clinical medicine at the University of Oxford and was awarded a PhD degree from the University of London for research on pathogenesis of arthritis. Professor Taylor has specialist clinical interests in inflammatory arthritis. He has over 25 years’ experience in clinical trial design in studies of biologic and small molecular therapies in rheumatoid arthritis and ankylosing spondylitis. In experimental medicine studies, Professor Taylor employs targeted therapies as probes of pathogenesis to investigate the in vivo biology of the target in the pathobiology of the disease phenotype under investigation.

    Jérôme Avouac

    Editor-in-Chief

    Michael Nurmohamed

    Amsterdam, The Netherlands

    Preventive cardiology in rheumatology

    Close Popup

    Michael Nurmohamed

    Editorial Board

    Amsterdam Rheumatology & Immunology Center, Amsterdam University Medical Center and Reade, Amsterdam, The Netherlands

    Amsterdam, The Netherlands

    Biography

    Michael T. Nurmohamed, MD PhD, is Professor Emeritus of Rheumatology and a consultant rheumatologist affiliated with the Amsterdam Rheumatology & Immunology Center at Reade and Amsterdam UMC, The Netherlands. His academic career has focused on the interface between inflammatory rheumatic diseases and cardiovascular disease, with a particular emphasis on cardiovascular risk management and prevention in conditions such as rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis and gout. He has played a leading role in European and international guideline development, including as convenor and chair of multiple EULAR task forces and study groups addressing cardiovascular involvement in inflammatory arthritis. His work has contributed to improved understanding of inflammation-driven atherosclerosis and to the implementation of cardiovascular risk assessment strategies in rheumatology care. Professor Nurmohamed has authored and co-authored numerous peer-reviewed publications and remains actively involved in international collaborations, clinical trials and educational initiatives. Following his emeritaat in November 2025, he remains actively involved in research, epidemiology, mentoring and international advisory roles within the rheumatology community, with a strong commitment to advancing interdisciplinary education and collaboration.

    Peter Taylor

    Honorary Board Member

    Vinod Ravindran

    Editorial Board
    RheumaPreg 2025 Vinod Ravindran International Conference on Reproduction, Pregnancy and Rheumatic Diseases

    Vinod Ravindran

    Centre for Rheumatology, Calicut, Kerala

    Rheumatic Diseases

    RheumaPreg 2025 Vinod Ravindran International Conference on Reproduction, Pregnancy and Rheumatic Diseases
    Close Popup

    Vinod Ravindran

    Editorial Board
    Centre for Rheumatology, Calicut, Kerala

    Biography

    Dr Vinod Ravindran’s clinical career includes training and consultant roles at premier institutions, such as King’s College Hospital, London and St. George’s University Hospital, London, Ipswich and Maidstone, UK.  Currently, he serves as the Director of the Centre for Rheumatology in Calicut, Kerala, India, where he leads comprehensive rheumatology services with a strong focus on multidisciplinary care.

    In addition to his clinical leadership, he is an Adjunct Professor of Medicine at the Kasturba Medical College, Manipal, Karnataka, where he teaches postgraduates and supervises PhD research. He is the president-elect of the Indian Rheumatology Association. He has a keen interest in reproductive rheumatology and is the co-convener of the APLAR SIG for Women’s Health in AIRDs and Convener of the Indian Rheumatology Association’s Reproductive Rheumatology SIG.

    Michael Nurmohamed

    Editorial Board

    Elena Nikiphorou

    Editorial Board

    Elena Nikiphorou

    Kings College London, London, UK

    Rheumatoid Arthritis

    Close Popup

    Elena Nikiphorou

    Editorial Board

    Centre for Rheumatic Diseases, School of Immunology and Microbial Sciences, King’s College London, London, UK

    Kings College London, London, UK

    Biography

    Dr Elena Nikiphorou is a Consultant Rheumatologist at King’s College Hospital and a Reader in Rheumatology and Medical Education at King’s College London. A recipient of several awards, including the Richard Kovacs Prize (Royal Society of Medicine, 2014) and the Doris Hillier Award (British Medical Association, 2018), her research focuses on multimorbidity in rheumatoid arthritis and the development of personalised management algorithms. Her clinical and academic interests focus on inflammatory arthritis, in particular rheumatoid arthritis and spondyloarthritis, with her latest research exploring the role of social determinants of health  in disease outcomes.

    Vinod Ravindran

    Editorial Board

    Peter Taylor

    Honorary Board Member
    touchIMMUNOLOGY touchIMMUNOLOGY

    Register Now!

    Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

    • Save your progress for video
    • Keep track of your CME credits
    • Add personalised learning notes
    • Receive updates from course leaders and faculty
    • Be the first to hear about new and exciting interactive learning opportunities
    Close Popup